Clear, Transparent Info Needed To Increase Diversity In Pediatric Trials

By Kelly Lienhard / March 4, 2021 at 1:41 PM
Pediatricians say vaccine developers need to make information about their COVID-19 clinical trials more accessible, especially to historically underrepresented minority groups, to encourage parents to enroll their children in trials now taking place to study the vaccines’ effects on children. The experts say it’s important to make information about trials transparent and easily available, including by offering information in multiple languages and making sure it’s culturally sensitive. The COVID-19 pandemic has brought to light the need for more diversity in...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.